Gemcitabine, fludarabine, and melphalan for reduced-intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory Hodgkin lymphoma in the brentuximab vedotin era Meeting Abstract
| Authors: | Anderlini, P.; Saliba, R.; Ledesma, C.; Plair, T.; Alousi, A.; Hosing, C.; Khouri, I.; Nieto, Y.; Popat, U.; Shpall, E.; Fanale, M.; Oki, Y.; Neelapu, S.; Younes, A.; Champlin, R. |
| Abstract Title: | Gemcitabine, fludarabine, and melphalan for reduced-intensity conditioning (RIC) and allogeneic stem cell transplantation (allo-SCT) for relapsed/refractory Hodgkin lymphoma in the brentuximab vedotin era |
| Meeting Title: | 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation |
| Journal Title: | Bone Marrow Transplantation |
| Volume: | 51 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Apr 3-6 |
| Meeting Location: | Valencia, Spain |
| ISSN: | 0268-3369 |
| Publisher: | Nature Publishing Group |
| Date Published: | 2016-03-01 |
| Start Page: | S70 |
| End Page: | S71 |
| Language: | English |
| ACCESSION: | WOS:000373357600117 |
| PROVIDER: | wos |
| PUBMED: | 26999536 |
| DOI: | 10.1038/bmt.2016.46 |
| Notes: | Meeting Abstract: O121 -- Source: Wos |
